Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00468208Phase 1/2Completed
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Wegener's Granulomatosis
Principalinvestigator
NCT00556439Phase 2Completed
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
Giant Cell ArteritisTakayasu's Arteritis
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The Cleveland Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Peter A. Merkel, MD, MPH

Boston University

Moderately Similar
2 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisGiant Cell ArteritisTakayasu Arteritis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Office of Rare Diseases (ORD)+2 more
Collaborated on 1 trial
Similarity Score34%

Amanda M. Terry, MA

University of South Florida College of Medicine

Moderately Similar
2 trials

Shared therapeutic areas:

Giant Cell ArteritisTakayasu ArteritisGranulomatosis with Polyangiitis

Worked with same sponsors:

University of Pennsylvania
Similarity Score30%

Peter C. Grayson, MD

Boston University

Moderately Similar
2 trials

Shared therapeutic areas:

Giant Cell ArteritisTakayasu ArteritisGranulomatosis with Polyangiitis

Worked with same sponsors:

University of Pennsylvania
Similarity Score30%

Peter A Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisGiant Cell ArteritisTakayasu Arteritis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Office of Rare Diseases (ORD)+3 more
Similarity Score30%

Peter Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
4 trials

Shared therapeutic areas:

Giant Cell ArteritisTakayasu ArteritisGranulomatosis with Polyangiitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Office of Rare Diseases (ORD)+2 more
Similarity Score30%

Peter A. Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisTakayasu ArteritisGiant Cell Arteritis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Office of Rare Diseases (ORD)+2 more
Similarity Score30%

Jeffrey P Krischer, PhD

University of South Florida

Related
3 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisGiant Cell Arteritis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Office of Rare Diseases (ORD)+3 more
Similarity Score20%

Juhong Shi, M.D

Peking Union Medical College Hospital

Related
8 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisTakayasu Arteritis
Similarity Score20%

Lindi Jiang, PhD

Fudan University

Related
7 trials

Shared therapeutic areas:

Takayasu ArteritisGranulomatosis with Polyangiitis
Similarity Score20%

Emmanuel Messas, MD

Hôpital Européen Georges-Pompidou

Related
2 trials

Shared therapeutic areas:

Takayasu Arteritis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00468208Phase 1/2PrincipalInvestigator

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

Wegener's Granulomatosis
Completed
NCT00556439Phase 2PrincipalInvestigator

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Giant Cell ArteritisTakayasu's Arteritis
Completed

All 2 trials loaded